View Older Stories View More Recent Stories
-
Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF95 at RBC Capital
-
Alcon Inc. (ALC) PT Lowered to $109 at Bernstein Following Soft Q1
-
Alcon (ALC) Misses Q1 EPS by 3c ; Offers Guidance
-
Alcon (ALC) call put ratio 1 call to 2 puts with a focus on June 92.50 and 100 puts
-
Alcon Inc. (ALC:SW) (ALC) PT Raised to CHF99 at Bernstein, Citing 'A Reassuring Outlook'
-
Alcon Inc. (ALC) PT Raised to $112 at KeyBanc
-
Alcon Inc. (ALC:SW) (ALC) PT Raised to CHF96 at Deutsche Bank
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
Alcon Inc. (ALC) PT Raised to $110 at Needham
-
Alcon Inc. (ALC) PT Raised to $120 at Mizuho
-
Alcon Inc. (ALC) PT Raised to $115 at Jefferies
-
Citi Reiterates Buy Rating on Alcon Inc. (ALC:SW) (ALC)
-
Alcon (ALC) Acquires Majority Interest in Aurion Biotech
-
Bernstein Reiterates Outperform Rating on Alcon Inc. (ALC) Post LENSAR Acquisition
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
BofA Securities Upgrades Alcon Inc. (ALC) to Buy
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
BofA Securities Upgrades Alcon Inc. (ALC:SW) (ALC) to Buy
-
Needham Reiterates Buy Rating on Alcon (ALC), 'view the risk/reward as attractive'
-
Bernstein SocGen Group Reinstates Alcon Inc. (ALC) at Outperform
-
Bernstein SocGen Group Reinstates Alcon Inc. (ALC:SW) (ALC) at Outperform
-
Algoma Central delivers three new vessels within one week
-
Alcon Inc. (ALC:SW) (ALC) PT Raised to CHF92 at Deutsche Bank
-
Alcon Inc. (ALC) PT Raised to $115 at Mizuho
-
Alcon (ALC) Tops Q4 EPS by 1c ; Offers Guidance
-
Alcon (ALC) March option implied volatility bid into quarter results
-
Alcon (ALC) Announces U.S. Launch of New SYSTANE PRO Preservative-Free
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
Alcon (ALC) announces launch of Volyager DSLT in U.S.
-
MedTech stocks 2025 preview: Here are KeyBanc's top picks
-
Alcon Inc. (ALC) PT Lowered to $106 at Needham
-
Alcon Inc. (ALC) PT Lowered to $105 at KeyBanc Amid FX Changes; Stock Highlighted as 'Key Idea'
-
Redburn-Atlantic Upgrades Alcon Inc. (ALC:SW) (ALC) to Buy
-
Alcon (ALC) 2700 contracts of January calls trade
-
Alcon Inc. (ALC) PT Raised to $108 at Needham, Added to Conviction List, Top Pick 2025
-
European MedTech 2025 outlook
-
KeyBanc Reiterates Overweight Rating on Alcon Inc. (ALC)
-
Alcon (ALC) Tops Q3 EPS by 7c ; Offers Guidance
-
Needham Reiterates Buy Rating on Alcon Inc. (ALC)
-
Alcon (ALC) call put ratio 10 calls to 1 put with a focus on November 90 calls into quarter results
-
Alcon (ALC) November 90 puts active into quarter results and outlook
-
Why traders should increase exposure to MedTech stocks: KeyBanc
-
Alcon Inc. (ALC) PT Raised to $107 at KeyBanc
-
Redburn-Atlantic Upgrades Alcon Inc. (ALC:SW) (ALC) to Neutral
-
Alcon Inc. (ALC) PT Raised to $104 at BTIG
-
RBC Capital Upgrades Alcon Inc. (ALC:SW) (ALC) to Outperform
-
Citi Reiterates Buy Rating on Alcon Inc. (ALC)
-
CFRA Reiterates Buy Rating on Alcon Inc. (ALC:SW) (ALC)
-
Alcon Inc. (ALC) PT Raised to $110 at Oppenheimer
-
Alcon Inc. (ALC) PT Raised to $110 at Baird

